ArticleMolecular therapy. Methods & clinical development2014

Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors.

Chuan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.